Christos Iatrou NEPHROLOGIST Director, Centre for diagnosis, treatment & research on kidney diseases

Medical School of the University of Athens

• Member of the Hellenic Society of Nephrology
  (I was a member of the Board for 8 years – General Secretary, Vice-President and President -2010-2012)
• Member of the Athens Medical Society
  (I was a member of the Board for 16 years and my last 8 years, General Secretary, Vice-President and President – 2006-2010)
• Member of the Hellenic Society for Medical Education
• Member of the Hellenic Society of Transplantation
• Member of the European Dialysis and Transplantation Association
• Member of the International Society of Nephrology
• Member of the American Society of Nephrology
• President of the Medical Society of Regenerative Medicine, Anti-Aging and Biotechnology
• Member of the Examination Committee for the administration of the Specialty Certificate in Nephrology, 2008-2018
• Alternate member of the Examination Committee for the Authorization of Ultrasound for Nephrologists, 2009-2018
• Member of the Committee of the Minister of Health for writing guidelines on urinary tract infections, 2005
• Member of the Committee for the Coordination of Actions on Monitoring the Implementation of Therapeutic Protocols, 2014-2016
• President of the Drug Committee at General Hospital of Nikaia-Pireaus , 2014-2018
• Member of the Secondary Committee at the National Medicine Agency, 2014-2015
• President of the Supreme Medical Council of the National Organization for Health Care Services (EOPYY) 2014-2019
• Member of Editorial Board of Hellenic Nephrology Journal, 2016-2019

• 2019 (Current Post): Director of the Center for the Diagnosis, Treatment and Research on Kidney Diseases (C.DI.T.R.KD), Hygeia Hospital
• 2001-2018: Chief, Centre for Nephrology, General Hospital of Nikaia-Piraeus
• 1998-2001: Assoc. Director, Nephrology Department, General Hospital of Athens “G. Gennimatas”
• 1989-1998: Senior Consultant, Nephrology Department, General Hospital of Athens “G. Gennimatas”
• 1986-1989: Consultant, Nephrology Department, General Hospital of Athens “G. Gennimatas
• 1987- 1988: Honorary Registrar & Research Fellow, St.Thomas Hospital, London, UK

Clinical Experience:

It concerns in all disciplines of nephrology (Clinical Nephrology, Hemodialysis, Peritoneal Dialysis and Kidney Transplantation) as I have worked as a trainee and specialist in Departments and Hospitals that are among the largest in their countries and manage  large numbers of patients across the whole spectrum of Nephrology.

Educational Activity in Nephrology:

• Teaching the pathophysiology of kidney diseases in third year students during my tenure at the Medical School of the University of Thessaly
• Teaching the Greek trainees in nephrology through many lectures and active participation in educational seminars of the Hellenic Society of Nephrology for 12 years
• Teaching 50 trainees in nephrology at General Hospital of Athens and General Hospital of Nikaia- Pireaus during the years of my work on them.
• Training doctors of other medical specialties in nephrology through many lectures in seminars or conferences.

• Glomerulonephritis (primary, secondary)
  (I was particularly interested in this subject during my training and my career in Nephrology and the last 17 years I developed one of the biggest Outpatient Clinic for Glomerulonephritis in our country in the Center for Nephrology at General Hospital of Nikaia-Pireaus)
• Chronic Kidney Disease (Chronic Renal Failure)
• Hemodialysis
  (I have been particularly interested in this subject from the beginning of my training in nephrology, I have written the first book in our country on hemodialysis membranes and during my career in Nephrology I have been a member or chair of several committees of the Ministry of Health in order to create specifications for hemodialysis filters and other supplies, as well as for treatment protocols for the application of the method
• Rare Diseases (Fabry Disease)

Research Interests:

• Glomerulonephritis
  (In recent years, the role of vitamin D in the pathogenesis of diabetic nephropathy and its therapeutic use in cases of other types of  glomerulonephritis)
• Hemodialysis
  (In recent years, mainly in the field of infections, costs and financial reimbursement)
• Chronic Kidney Disease
  (Especially in delaying the progression of the damage or improving the renal function using new innovative cell and gene therapies from the field of Regenerative Medicine)

• Prize at the 32nd EDTNA-ERCA for the study: Overweight patients are at increased risk of inadequate hemodialysis
  A.Petraki, K.Metaxouli, P.Marinaki, N.Selemidi, P.Galani, S.Kydonaki, A.Katopodi, C.Iatrou
• Prize at the 33rd EDTNA-ERCA for the study: Does the economic situation of dialysis patients affect the nutrition status?
  A.Petraki.Antoniadou, P.Marinaki, Th.Veliotis, P.Galani, C.Asiki, N.Selemidis, E.KibaroglouA. Magalia, C.Iatrou
• Prize at the 17th Panhellenic Congress of Nephrology for the study: Molecular mechanisms of action of vitamin D and its receptor, VDR in morphological and functional properties of the podocytes
  S.Verouti, G.Drosopoulou, L.Frangopoulou, A.Haronis, K.Dimopoulos, E.K.  Tsillibaris, C.iatrou
• Honorary Distinction of the Municipality of Nikaia-Pireaus for the Contribution in Medical Science, 2002
• Honorary Distinction of the Hellenic Society for Research and Education in Primary Health Care for the significant contribution to the achievement of its scientific goals, 2006
• Honorary Distinction of the Athens Medical Society for the significant contribution to science and education, 2010
• Honorary Distinction of the Athens Medical Society for the presidency period 2006-2010,2019
• Honorary Distinction of the Panhellenic Association of Kidney Diseases Patients “G. Kastrinakis” for the Multiannual Supply to the  patients with kidney diseases, 2019

• Dialysis Membranes
• Substitution Techniques for Rrenal Function in ICU
• Erythropoietic Factors: Clinical Applications

• IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology.
  Stangou M, Papasotiriou M, Xydakis D, Oikonomaki T, Marinaki S, Zerbala S, Stylianou C, Kalliakmani P, Andrikos A, Papadaki A, Balafa O, Golfinopoulos S, Visvardis G, Moustakas G, Papachristou E, Kouloukourgiotou T, Kapsia E, Panagiotou A, Koulousios C, Kavlakoudis C, Georgopoulou M, Panagoutsos S, Vlahakos DV, Apostolou T, Stefanidis I, Siamopoulos K, Tzanakis I, Papadogiannakis A, Daphnis E, Iatrou C, Boletis JN, Papagianni A, Goumenos DS.
  Clin Kidney J. 2018 Feb;11(1):38-45.
• Τhe family of 14-3-3 proteins and specifically 14-3-3σ are up-regulated during the development of renal pathologies.
  M, Frangou EA, Marineli F, Prakoura N, Zoidakis J, Gakiopoulou H, Liapis G,Kavvadas P, Chatziantoniou C, Makridakis M, Vlahou A, Boletis J, Vlahakos D, Goumenos D, Daphnis E, Iatrou C, Charonis AS.
  J Cell Mol Med. 2018; 22(9):4139-4149.
• Ethanol combined with heparin as a locking solution for the prevention of Catheter related blood stream infections in hemodialysis patients: A prospective randomized study
  Sofroniadou S,Revela I,Kouloubinis A,Makriniotou I,Zerbala S,Smirloglou D,Kalocheretis P,Drouzas A,Samonis G,Iatrou C
  Hemodial Int 2017; 21(4): 498-506
• Vitamin D3 ameliorates podocyte injury through the nephrin signaling pathway
  Trohatou O,tsilibary EF,charoniw A,Iatrou C,Drossopoulou G
  J Cell Mol Med 2017; 21(10):2599-2609
• Cost calculations during “dire straits” : a cost – of – illness analysis of regular hemodialysis for end-stage renal disease in Greece
  Naoum. I. Topkaroglou, D. Kitsonis, A. Skroumpelos, K. Athanasakis, C. Iatrou, J. Boletis, J. Kyriopoulos
  Int. J. Artif Organs 2016; 39(2) : 87-9
• Multicenter epidemiological study to assess the population of CKD patients in Greece: Results from the Prestar Study
  Sombolos, D. Tsakiris, J. Boletis, D. Vlahakos, K.C.Siamopoulos, V. Vargemezis, P. Nikolaidis, C. Iatrou, E. Dafnis, K. Xynos, C. Argyropoulos
  Nephr. Refer. And CKD Epidemiology. 2014 (9) :11
• Conservative care in Europe-nephrologists experience with the decision not to start renal replacement therapy
  Van de Luijtgaarden, M. Noordzij, W. Van Biesen, C.Couchoud, G. Cancarini, WJ. Bos, FW. Dekker, JL, Gorriz, C.Iatrou, C.Wanner, P.Finne,  O.Stojceva-Taneva, S. Cala , VS.Stel, C.Tomson, KJ. Jager
  Nephrol Dial Transplant. 2013 Oct; 28(10):2604-12
• Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients
  Verouti, AB. Tsoupras, F. Alevizopoulou, CA. Demopoulos, C.Iatrou
  Int. J Artif Organs. 2012; 36(2): 87-96
• Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytesVerouti, EC. Tislibary, E. Fragopoulou, C. Iatrou, CA. Demopoulos, AS. Charonis, SA. Charonis, GI. Drossopoulou.
  Nephron Exp Nephrol 2012; 122 (1-2):36-50
• Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study
  S.Sofroniadou, I.Revela, D.Smirloglou, I.Makriniotou, S.Zerbala, A.Kouloubinis, G.Samonis, C.Iatrou|
  Semin Dial 2012; 25(3) : 344-350